Back to People & Entities
Sum of Parts Value
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
Document Mentions (1)
EFTA00810576.pdf
1 mentionEFTA00810576
ion of CIM Securities Veru, Inc. (VEAL)) / April 05, 2018 Figure 3: Veru BioPharma Sum of Parts Valuation TAMSULOSIN DRS(XR Pipeline premium 25% Sum of Parts Value (SM) NPV per share Expected Launch Probability of Peak Market Peak Sales Probability Success Share (SM) adjusted NPV 2020E 33% 10% S886
Sponsored
Connected Entities
No connected entities